Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2017
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cook Medical
- 09 Nov 2017 Planned End Date changed from 1 Feb 2018 to 1 Jun 2018.
- 09 Nov 2017 Planned primary completion date changed from 1 Feb 2018 to 1 Jun 2018.
- 30 Aug 2017 3 year results of the diabetic and in-stent restenosis subgroups presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology